Mesenchymal Stromal Cells

Biology of Blood and Marrow Transplantation

Volumn 13, Issue SUPPL. 1, 2007, Pages 53-57

  Horwitz, Edwin M ^a   Andreef, Michael ^b   Frassoni, Francesco ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

GVHD; Mesenchymal stromal cells; MSCs immune modulation; Tumor targeting cell therapy

Indexed keywords

ADENOVIRUS VECTOR; RECOMBINANT BETA INTERFERON;

ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CANCER INHIBITION; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL THERAPY; CELL TYPE; DISEASE MODEL; DRUG DELIVERY SYSTEM; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HUMAN; HURLER SYNDROME; MESENCHYME CELL; METACHROMATIC LEUKODYSTROPHY; METASTASIS; NOMENCLATURE; OSTEOGENESIS IMPERFECTA; PHENOTYPE; STROMA CELL; TISSUE REGENERATION;

EID: 33845980572     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.10.016     Document Type: Article

References (24)

1. Horwitz E.M., and Keating A. Nonhematopoietic mesenchymal stem cells: what are they?. Cytotherapy 2 (2000) 387-388
2. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., and Frolova G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6 (1968) 230-247
3. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2 (1974) 83-92
4. Owen M., and Friedenstein A.J. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136 (1988) 42-60
5. Caplan A.I. Mesenchymal stem cells. J Orthop Res 9 (1991) 641-650
6. Horwitz E., Le Blanc K., Dominici M., et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 7 (2005) 393-395
7. Muguruma Y., Yahata T., Miyatake H., et al. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 107 (2006) 1878-1887
8. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
9. Barry F.P., Boynton R.E., Haynesworth S., Murphy J.M., and Zaia J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 265 (1999) 134-139
10. Barry F., Boynton R., Murphy M., and Zaia J. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun 289 (2001) 519-524
11. Dominici M., Le Blanc K., Mueller I., et al., The International Society for Cellular Therapy position statement. Minimal criteria for defining multipotent mesenchymal stromal cells. Cytotherapy 8 (2006) 315-317
12. Horwitz EM, Gordon PL, Koo WKK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 99, 8932-8937.
13. Koc O.N., Day J., Nieder M., et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30 (2002) 215-222
14. Koc O.N., Gerson S.L., Cooper B.W., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18 (2000) 307-316
15. Lazarus H.M., Koc O.N., Devine S.M., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11 (2005) 389-398
16. Le Blanc K., and Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 321-334
17. Glennie S., Soeiro I., Dyson P.J., Lam E.W., and Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105 (2005) 2821-2827
18. Ringden O., Uzunel M., Rasmusson I., et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81 (2006) 1390-1397
19. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
20. Zappia E., Casazza S., Pedemonte E., et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106 (2005) 1755-1761
21. Studeny M., Marini F.C., Champlin R.E., Zompetta C., Fidler I.J., and Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62 (2002) 3603-3608
22. Studeny M., Marini F.C., Dembinski J.L., et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted delivery vehicles of anti-cancer agents. J Natl Cancer Inst 96 (2004) 1593-1603
23. Marini F., Hall B., Dembinski J., et al. Mesenchymal stem cells as vehicles for genetic targeting of tumors. In: Ho A.D., Hoffman R., and Zanjani E.D. (Eds). Stem Cell Transplantation (2006), Wiley-VCH Verlag, Weinheim, Germany 157-175
24. Nakamizo A., Marini F., Studeny M., et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65 (2005) 3307-3318